Use of Doxycycline to Prevent Sexually Transmitted Infections According to Provider Characteristics

Pearson, William S.; Emerson, Brian; Hogben, Matthew; Barbee, Lindley

doi:10.3201/eid3001.231152

i

Use of Doxycycline to Prevent Sexually Transmitted Infections According to Provider Characteristics

Supporting Files Public Domain

1 2024
By Pearson, William S. ; Emerson, Brian ; Hogben, Matthew
http://dx.doi.org/10.3201/eid3001.231152

File Language:

English

Details

Alternative Title:

Emerg Infect Dis
Personal Author:

Pearson, William S. ; Emerson, Brian ; Hogben, Matthew ; Barbee, Lindley
Description:

Use of doxycycline to prevent sexually transmitted infections (STIs) may lead to antimicrobial resistance. We analyzed attitudes toward this practice between US providers who commonly and less commonly treat STIs. Providers who more commonly treat STIs are more likely to prescribe prophylactic doxycycline and believe that benefits outweigh potential for increased antimicrobial resistance.
Subjects:
Keywords:
Source:

Emerg Infect Dis. 2024; 30(1):197-199
Pubmed ID:

38147529
Pubmed Central ID:

PMC10756361
Document Type:

Journal Article
Place as Subject:

United States
Volume:

30
Issue:

1
Download URL:

https://stacks.cdc.gov/view/cdc/140586/cdc_140586_DS1.pdf
File Type:

[PDF - 477.67 KB]
Collection(s):

Emerging Infectious Diseases
Main Document Checksum:

urn:sha256:3a5796b0442d9cf36dcb8d15c03a6b6d65a4efcc55e8becdc2572150bd8fa5fd

File Language:

English

ON THIS PAGE

Details Supporting Files

Was this page helpful?

Found an issue?

Send us an email at:

publishinghd@cdc.gov

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.